Trials / Completed
CompletedNCT01392794
A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional Tablet
Bioequivalence Study of YM060 Orally-disintegrating Tablet and Conventional Tablet - Ingestion Without Water
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
A study to compare time-course changes of plasma concentration of YM060 after intake of conventional tablet and orally-disintegrating tablet. Orally-disintegrating tablets will be administered without water.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM060 | oral, without water |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2011-07-13
- Last updated
- 2011-07-13
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01392794. Inclusion in this directory is not an endorsement.